FMC Corp. (FMC) stock plunges as UBS downgrades, citing potential risks in crop chemicals demand and execution strategy.
UBS downgraded FMC Corporation (NYSE:FMC) to "Neutral" from "Buy" given increased execution risks tied to the company's strategic pivot and ongoing pressure from declining crop chemical demand. The ...
We recently compiled a list of the Jim Cramer Discusses These 9 Stocks & US AI GPU Advantages. In this article, we are going ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...
J.P. Morgan analyst Jeffrey Zekauskas maintained a Hold rating on FMC (FMC – Research Report) yesterday and set a price target of $36.00. The ...
UBS downgraded FMC (FMC) to Neutral from Buy with a price target of $38, down from $66. The firm no longer sees the potential for a 2025 market ...
UBS analyst Joshua Spector downgraded shares of FMC Corp . (NYSE: NYSE:FMC) from Buy to Neutral, significantly reducing the price target from $66.00 to $38.00. The adjustment reflects concerns over ...